Medi Ventures invests in miRdetect GmbH

MUNICH, GERMANY, January 20, 2020  — Dentons Venture Technology and Emerging Growth practice advised miRdetect GmbH, a biotechnology company providing testing and diagnostics services in the investment made by Medi Ventures. Partner Thomas Strassner led the Dentons team advising miRdetect GmbH on the transaction.